Tg Therapeutics, Inc. (NASDAQ:TGTX) has 341 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 548,037 | 2.57% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 319,703 | 2.06% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | -705,419 | -18.35% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -358,562 | -44.53% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 379,380 | 4.68% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -148,503 | -9.23% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 247,733 | 557.44% | $0.00 |
| Clearbridge Investments, LLC | 31 Dec, 2025 | 0 | -1,196,442 | -25.76% | $0.00 |
| Man Group plc | 31 Dec, 2025 | 0 | -51,825 | -5.14% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 234,571 | 1,320.34% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -40,053 | -1.16% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 242,434 | 34.11% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 531,759 | 35.00% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 347,888 | 68.94% | $0.00 |
| CONGRESS ASSET MANAGEMENT CO | 31 Dec, 2025 | 0 | 1,922,410 | 0.00% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -81,209 | -13.14% | $0.00 |
| Invesco Ltd. | 31 Dec, 2025 | 0 | 515,481 | 47.10% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | 246,057 | 92.36% | $0.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 0 | 28,446 | 1.83% | $0.00 |
| Occam Crest Management LP | 31 Dec, 2025 | 0 | -8,000 | -1.95% | $0.00 |